In order to minimise the potential for diagnostic delays and to otherwise ensure the veracity of results produced by our laboratories, the pathology department requests that clinicians familiarise themselves with the following general rules on sample acceptability...
In addition to these general considerations, there are laboratory-specific sample acceptance criteria that must be met also - please see respective Biochemistry, Haematology and Microbiology-department guidance for full details.
Unlabelled specimens: specimens received into the laboratory will be rejected and discarded to clinical waste (exceptions may be made for “precious”specimens e.g. a biopsy or CSF specimen for which the provenance can be reasonably assured and the requesting is physician contacted who will assume full responsibility for any data derived from such specimens; - these will be referred to the relevant pathology clinical lead or senior BMS staff for individual consideration.)
Mismatched specimens: specimens that are received that include the name of one patient on the specimen and the name of another patient on the accompanying request form will be rejected.
If the laboratory is contacted by a ward/clinical area stating they have mislabelled a specimen, it will not be possible to return specimens for re-labelling as the integrity of the specimen cannot be guaranteed in such cases - a repeat specimen MUST instead be obtained and sent to pathology. Specimens with other information mismatches will be queried by reception staff and if necessary the ward will be contacted to determine the correct full identification of the patient.
Wrong specimen types
Specimens that are received in the wrong specimen container or the wrong specimen type for a given investigation will be rejected and a comment made on the laboratory information system. Please refer to advice on labile biochemical investigations or the Pathology test directory for specific sample requirements.
Mention should be made also of samples that have been received into the laboratory, for which following analysis there appears to be a strong suspicion that pre-analytical cross-contamination may have taken place. Clinicians are requested to ensure there is no interchange of samples at phlebotomy.
Ensure that the correct order of draw procedure is observed at all times.
Please refer to the S-Monovette Tube Guide
and Homerton Blood Tube Order of Draw Guidance
Leaking or Unsafe specimens: these specimens will be discarded upon receipt. For specimens that are not repeatable (e.g. CSF, Histology or pre-treatment Microbiology specimens) all reasonable steps will be taken to decontaminate the outer surfaces of the specimen container and the specimen re-sealed for subsequent processing. A comment will be entered in the results on WinPath to indicate what has happened.
Last updated: 11 November 2016